Anavex Life Sciences Corp (AVXL)

[BAR123]

With my 40 years experience with working for fortune 500 businesses and investing in biotech, it is my belief that the company will be sold within 12 months. All the talk about executives leaving is nonsense. The company will be partnering with a large company, probably very soon. That company will be probably giving Anavex about $1B for a stake in the company. That stake could happen at $30pps which would value the company at about $2.5B give or take. The partnership could drive us much higher shortly after the market absorbs it. The partner might be doing more than just sales and marketing. Maybe they take some control over some of the new indications as well, meaning they are responsible for the trials going forward. That could be the reason why they don't need some of the executives who got them this far in the trial / approval cycle. So with any great news coming like FDA guidance, EMA guidance/clock stop passing, great data from the schizophrenia 371 trial, any other data, etc maybe we get the stock up to $50 in the next 25 days - 6 months. With approval we go to $80 and a buyout gets us to $150 in about 12 months give or take a few months. Plausible?